Percutaneous radiofrequency ablation (RFA) has emerged as an alternative modality for treatment of small renal tumors. The increasing use of imaging studies has allowed for early detection of renal tumors and the advent of minimally invasive nephron-sparing approaches. The use of percutaneous RFA achieves acceptable oncologic and functional outcomes when compared to partial nephrectomy, the "gold standard" in managing small renal masses. Percutaneous RFA is safe and cost-effective in treating renal tumors.
- Ablative technology
- Nephron-sparing surgery
- Percutaneous radiofrequency ablation
- Small renal tumors
ASJC Scopus subject areas